Table 1 Clinical characteristics of patients
Patient ID | Cohort | Atovaquone | Interval between scans (days) | PET tracer | Age (years)/sex | TNM staging | Tumour volume (mL) |
|---|---|---|---|---|---|---|---|
10001 | 1 | Yes | 13 | FMISO | 58/M | T3 N0 M0 | 89.5 |
10004 | 1 | Yes | 8 | FAZA | 71/F | T4 N3 M0 | 184.9 |
10005 | 1 | Yes | 14 | FMISO | 72/M | T2a N2 M0 | 61.0 |
10,006 | 1 | Yes | 14 | FMISO | 69/M | T4 N2 M0 | 179.5 |
10008 | 1 | Yes | 10 | FMISO | 77/F | T2a N0 M0 | 17.8 |
10009 | 1 | Yes | 14 | FMISO | 78/M | T3 N0 M0 | 59.3 |
10010 | 1 | Yes | 13 | FMISO | 70/M | T4 N2 M0 | 371.1 |
10011 | 1 | Yes | 8 | FMISO | 77/F | T4 N0 M0 | 24.6 |
10013 | 1 | Yes | 9 | FMISO | 54/F | T1c N3 M0 | 15.5 |
10014 | 1 | Yes | 13 | FMISO | 55/F | T3 N0 M0 | 42.2 |
10016 | 1 | Yes | 14 | FMISO | 57/F | T2a N0 M0 | 30.6 |
10019 | 1 | Yes | 14 | FMISO | 58/M | T4 N0 M0 | 366.9 |
10020 | 1 | Yes | 14 | FMISO | 73/M | T3 N0 M0 | 85.3 |
10022 | 1 | Yes | 14 | FMISO | 65/F | T2b N1 M0 | 45.9 |
10023 | 1 | Yes | 8 | FMISO | 58/F | T3 N0 M0 | 33.4 |
10024 | 2 | No | 13 | FMISO | 68/M | T3 N1 M0 | 45.8 |
10025 | 2 | No | 14 | FMISO | 71/M | T4 N0 M0 | 40.8 |
10028 | 2 | No | 14 | FMISO | 53/M | T3 N1 M0 | 20.6 |
10029 | 2 | No | 14 | FMISO | 87/M | T2b N1 M0 | 24.1 |
10030 | 2 | No | 7 | FMISO | 57/M | T3 N2 M0 | 243.0 |
10031 | 2 | No | 15 | FMISO | 58/F | T3 N0 M1b | 5.4 |
10033 | 2 | No | 14 | FMISO | 75/M | T1c N0 M0 | 6.3 |
10034 | 2 | No | 14 | FMISO | 63/M | T1b N1 M0 | 43.7 |
10037 | 2 | No | 11 | FMISO | 70/M | T2a N0 M0 | 19.1 |
10039 | 2 | No | 14 | FMISO | 67/M | T4 N0 M0 | 144.8 |
10041 | 2 | No | 7 | FMISO | 61/M | T2a N1 M0 | 20.0 |
10043 | 2 | No | 7 | FMISO | 69/F | T4 N0 M0 | 80.7 |
10044 | 2 | No | 8 | FMISO | 62/F | T3 N1 M0 | 45.3 |
10045 | 2 | No | 2 | FMISO | 81/M | T3 N0 M0 | 185.4 |
10046 | 2 | No | 14 | FMISO | 70/M | T3 N0 M0 | 57.5 |